The results of immunohistochemistry and WB showed that CTLA-4, CD80, and CD86 were higher in the HCC and SD-HCC groups than in the other groups, and it was significantly higher in the SD-HCC group. This evidence concerns the gene CD80 and hepatocellular carcinoma.